Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
57.32
+0.63 (1.11%)
Sep 30, 2026, 2:05 PM EDT - Market open
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $8.53 billion as of September 30, 2026. Its market cap has increased by 89.61% in one year.
Market Cap
8.53B
Enterprise Value
7.16B
1-Year Change
89.61%
Ranking
Category
Stock Price
$57.32
ChartMarket Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $8.53B, an increase of 518.10%. That is a compound annual growth rate of 33.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 8.53B | 41.22% |
| Dec 31, 2025 | 6.04B | -40.80% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kymera Therapeutics | 9.31B |
| Arrowhead Pharmaceuticals | 9.25B |
| Protagonist Therapeutics | 9.22B |
| Cytokinetics | 9.20B |
| ImmunityBio | 9.03B |
| Caris Life Sciences | 8.97B |
| ABIVAX Société Anonyme | 8.31B |
| Praxis Precision Medicines | 7.98B |